参考文献/References:
[1]Beg S, Ragunath K, Wyman A, et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut,2017,66(11):1886-1899.
[2]吴会晓,唐旭东,柯俊,等.无痛电子胃镜和普通电子胃镜上消化道疾病检出率的分析.现代消化及介入诊疗,2020,25(10):1359-1363.
[3]Senoner T, VelikSalchner C, Luckner G, et al. Anesthesiainduced oxidative stress: Are there differences between intravenous and inhaled anesthetics? Oxid Med Cell Longev,2021,2021:8782387.
[4]Chu L, Zhao J, Sheng C, et al. Confocal laser endomicroscopy under propofolbased sedation for early gastric cancer and precancerous lesions is associated with better diagnostic accuracy: a retrospective cohort study in China. BMC Anesthesiol,2021,21(1):97.
[5]Hemmings HC Jr, Mackie K. The rivers of Lethe and Mnemosyne converge: propofol and memory consolidation. Anesthesiology,2011,114(6):1277-1279.
[6]Walsh CT. Propofol: Milk of amnesia. Cell,2018,175(1):10-13.
[7]Bolkenius D, Dumps C, Halbeck E. Drugs for intravenous induction of anesthesia: propofol. Anaesthesist,2018,67(2):147-162.
[8]李玲瑶,李术榕,李响,等.环泊酚临床应用现状及研究进展.心肺血管病杂志,2023,42(1):97-99.
[9]环泊酚临床应用指导意见专家小组.环泊酚临床应用指导意见(2023).中华麻醉学杂志，2023,43(7):769-772.
[10]Long YQ, Feng CD, Ding YY, et al. Esketamine as an adjuvant to ciprofol or propofol sedation for sameday bidirectional endoscopy: protocol for a randomized, doubleblind, controlled trial with factorial design. Front Pharmacol,2022,13:821691.
[11]Liu Y, Chen C, Liu N, et al. Efficacy and safety of ciprofol sedation in ICU patients with mechanical ventilation: A clinical trial study protocol. Adv Ther,2021,38(10):5412-5423.
[12]石敏,景卫,李红岩.环泊酚与丙泊酚在老年患者无痛胃镜检查中的效果比较分析.中外医疗,2024,43(17):104-107.
[13]Qin K, Qin WY, Ming SP, et al. Effect of ciprofol on induction and maintenance of general anesthesia in patients undergoing kidney transplantation. Eur Rev Med Pharmacol Sci,2022,26(14):5063-5071.
[14]Hara M, Kai Y, Ikemoto Y. Enhancement by propofol of the gammaaminobutyric acidA response in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology,1994, 81(4):988-994.
[15]Qin L, Ren L, Wan S, et al. Design, synthesis, and evaluation of novel 2,6disubstituted phenol derivatives as general anesthetics. J Med Chem,2017,60(9):3606-3617.
[16]Wei Y, Qiu G, Lei B, et al. Oral delivery of propofol with methoxymethylphosphonic acid as the delivery vehicle. J Med Chem,2017,60(20):8580-8590.
[17]Liao J, Li M, Huang C, et al. Pharmacodynamics and pharmacokinetics of HSK3486, a novel 2,6disubstituted phenol derivative as a general anesthetic. Front Pharmacol,2022,13:830791.
[18]Bian Y, Zhang H, Ma S, et al. Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects. Br J Clin Pharmacol,2021,87(1):93-105.
[19]Liu SB, Yao X, Tao J, et al. Population total and unbound pharmacokinetics and pharmacodynamics of ciprofol and M4 in subjects with various renal functions. Br J Clin Pharmacol,2023,89(3):1139-1151.
[20]“环泊酚临床应用指导意见”专家小组.环泊酚临床应用指导意见.中华麻醉学杂志,2021，41(2):129-132.
[21]Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet,2018,57(12):1539-1558.
[22]施小红,李育蓉.环泊酚在门诊无痛胃肠镜麻醉中的应用效果研究.北方药学,2023,20(8):101-103.
[23]张俊伟,胡艳辉,李之明.环泊酚在无痛胃肠镜麻醉中的应用研究.中国现代药物应用,2022,16(16):35-38.
[24]马艳辉,连一闻,刘芳妍,等.小剂量艾司氯胺酮对环泊酚用于无痛胃肠镜检查麻醉诱导半数有效剂量的影响.临床麻醉学杂志,2024,40(5):458-462.
[25]赵娟,姚洪林,刘利君.环泊酚复合芬太尼在胃镜检查中的应用剂量分析.中国内镜杂志,2024,30(6):74-79.
[26]黄瑾,张珈硕,韩亚楠,等.重度吸烟因素对复合阿芬太尼时环泊酚用于无痛胃镜检查术量效关系的影响.中华麻醉学杂志,2024,44(7):826-829.
[27]高子雯,周日华,李家新,等.环泊酚复合纳布啡在老年无痛胃肠镜诊断和治疗中的应用.武警医学,2023,34(4):330-334.
[28]Xiong H, Xu H, Yang Y, et al. Median effective dose of ciprofol combined with sufentanil for inhibiting the upper gastrointestinal endoscopic placement reaction in elderly patients. Dose Response,2024,22(2):15593258241248931.
[29]方志勇,仇晓娟,冯涛,等.联合布托啡诺时环泊酚在老年患者无痛胃镜检查中的有效剂量及安全性.实用临床医药杂志,2024,28(12):82-85.
[30]徐海,朱婷婷,周红梅.性别因素对环泊酚复合阿芬太尼抑制老年患者无痛胃镜置入反应半数有效剂量的影响.现代实用医学,2024,36(2):224-226.
[31]汤淑婷,陈嘉栋,上官明化.肥胖患者门诊无痛胃肠镜检查中分别使用环泊酚和丙泊酚进行麻醉的效果比较.中国药物滥用防治杂志,2023,29(12):2085-2088.
[32]刘澳华,赵盼盼,李北平,等.环泊酚复合瑞芬太尼应用于肥胖患者无痛胃镜麻醉效果分析.临床和实验医学杂志,2023,22(11):1230-1233.
[33]郑龙彬,秦卫民,梁文波,等.环泊酚复合舒芬太尼用于肥胖患者无痛胃镜检查的效果.临床麻醉学杂志,2024,40(5):557-559.
[34]Devlin JW, Lau AK, Tanios MA. Propofolassociated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy,2005,25(10):1348-1352.
[35]Cremer OL. The propofol infusion syndrome: more puzzling evidence on a complex and poorly characterized disorder. Crit Care,2009,13(6):1012.
[36]赫阳森,赵二贤,李莉,等.环泊酚复合阿芬太尼用于糖尿病患者无痛胃镜检查术的优化效应观察.世界临床药物,2023,44(6):604-607,660.
[37]芦智波,刘萍,滕琦,等.环泊酚联合瑞芬太尼用于室性心律失常患者无痛胃肠镜检查中的安全性及应激反应.心血管病防治知识,2023,13(31):31-34.
[38]Zhou R, Fu L, Liu S, et al. Influences of propofol, ciprofol and remimazolam on dreaming during anesthesia for gastrointestinal endoscopy: A randomized doubleblind paralleldesign trial. Drug Des Devel Ther,2024,18:1907-1915.
[39]Cao X, Zhou J, Xu M, et al. Incidence of dreaming during ciprofol anesthesia for painless gastroscopy. Minerva Anestesiol,2024,90(4):271-279.
[40]Li T, Zhang J, Liu Z, et al. Effect of propofol and ciprofol on the euphoric reaction in patients with painless gastroscopy: A prospective randomized controlled trial. Heliyon,2024,10(9):e30378.
[41]Yang Y, Lang Z, Wang X，et al. Comparison of the efficacy and safety of ciprofol and propofol in sedating patients in the operating room and outside the operating room: a metaanalysis and systematic review. BMC Anesthesiol,2024,24(1):218.